Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal - The New York Times
- Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal The New York Times
- Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits CNBC
- Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition Fox Business
- Pfizer to Buy Metsera for $10 Billion, Capping Bidding War Bloomberg.com
- Novo Nordisk gives up battle for Metsera as Pfizer inks $10B deal Seeking Alpha